Japan Eyes $630 Billion Health-Care Market By 2020, 20% In Foreign Sales
This article was originally published in PharmAsia News
Executive Summary
Japan plans a national revitalization strategy that includes boosting the health-care market to nearly $630 billion by 2020, more than $21 billion of it earmarked for regenerative medicines and other advanced fields.